Bioventus (BVS) Capital Expenditures (2020 - 2026)
Bioventus' (BVS) quarterly Capital Expenditures came in at $534000.0 in Q1 2026, down 35.35% YoY from $826000.0 in Q1 2025, and down 7.93% on a QoQ basis from $580000.0 in Q4 2025.
Bioventus (BVS) Capital Expenditures (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Capital Expenditures data on file, last reported at $534000.0 in Q1 2026.
- Quarterly Capital Expenditures fell 35.35% year-over-year to $534000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 47.31% YoY) and the FY2025 annual result came in at $2.6 million, up 154.67% from the prior year.
- Capital Expenditures fell to $534000.0 in Q1 2026, from $580000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $4.9 million in Q3 2022 to a low of -$6.2 million in Q4 2022.
- A 5-year average of $343058.8 and a median of $336000.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 12657.14% — and 2025, when it tumbled 632.56%.
- Tracing BVS's Capital Expenditures over 5 years: stood at -$6.2 million in 2022, then soared by 100.11% to $7000.0 in 2023, then jumped by 12657.14% to $893000.0 in 2024, then tumbled by 35.05% to $580000.0 in 2025, then declined by 7.93% to $534000.0 in 2026.
- The last three Capital Expenditures figures came in at $534000.0 (Q1 2026), $580000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 960,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 960,000.00 |
| Jun 27, 2026 | 960,000.00 |
| Mar 28, 2026 | 534,000.00 |
| Mar 28, 2026 | 534,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Sep 27, 2025 | 1.79 Mn |
| Sep 27, 2025 | 1.79 Mn |
| Jun 28, 2025 | -630,000.00 |
| Jun 28, 2025 | -630,000.00 |
| Mar 29, 2025 | 826,000.00 |
| Mar 29, 2025 | 826,000.00 |
| Dec 31, 2024 | 893,000.00 |
| Dec 31, 2024 | 893,000.00 |
| Sep 28, 2024 | -92,000.00 |
| Sep 28, 2024 | -92,000.00 |
| Jun 29, 2024 | -86,000.00 |
| Jun 29, 2024 | -86,000.00 |
| Mar 30, 2024 | 291,000.00 |
| Mar 30, 2024 | 291,000.00 |